[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diagnostics & Diseases Market Research Reports & Industry Analysis

Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).

A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.

This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.

Publications found: 43,318
Sort by:

2014 Analysis of the Diagnostic Testing Market US Physician Offices and Group Practices: Supplier Shares and Sales Forecasts for Over 300 Tests

US$ 10,000.00

... Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products Analysis of over 130 diagnostic procedures. Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, ...

November 2013 970 pages

2014 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers

US$ 4,400.00

... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...

November 2013 795 pages

2014 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...

November 2013 238 pages

2014 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...

November 2013 373 pages

2014 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...

November 2013 418 pages

2014 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 2,320.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers ...

November 2013 337 pages

2014 Analysis of the POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 2,320.00

... from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, ... appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry ...

November 2013 305 pages

2014 Analysis of the US Home/Self Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood Business Challenges and Marketing Strategies for Suppliers

US$ 1,160.00

This new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes ( ... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of the home/self testing market segments, including diabetes ( ...

November 2013 175 pages

2014 Analysis of the French Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics ...

November 2013 585 pages

2014 Analysis of the Italian Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

November 2013 570 pages

2014 Analysis of the German Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics ...

November 2013 585 pages

2014 Analysis of the Japanese Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 6,000.00

Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

November 2013 590 pages

2014 Analysis of the Spanish Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

November 2013 565 pages

2014 Analysis of the UK Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

November 2013 575 pages

2014 Analysis of the US Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 7,760.00

Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...

November 2013 620 pages

2014 Analysis of the Nucleic Acid Testing in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European ...

November 2013 970 pages

2014 Analysis of the Global Nucleic Acid Testing Market: Innovative Technologies and Emerging Business Opportunities

US$ 22,800.00

... -year test volume and sales projections by country. Market Segmentation Analysis Sales and market shares of major suppliers of NAT reagent kits ... volume and sales projections for over 30 NAT assays. A comprehensive analysis of the sequencing market, by country and laboratory segment, including: Industrial ...

November 2013 1050 pages

2014 Analysis of the German Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 850-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2013 850 pages

2014 Analysis of the Italian Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 850-page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...

November 2013 850 pages

2014 Analysis of the Japanese Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 6,800.00

Highlights Comprehensive 850-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...

November 2013 850 pages

2014 Analysis of the Spanish Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 850-page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...

November 2013 850 pages

2014 Analysis of the UK Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 855-page market segmentation analysis of the UK NAT market. Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review ...

November 2013 855 pages

2014 Analysis of the US Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 7,600.00

Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review ...

November 2013 880 pages

2014 Analysis of the French Nucleic Acid Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 5,360.00

Highlights Comprehensive 850-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

November 2013 850 pages

2014 Analysis of the Global Endocrine Function Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan

US$ 6,800.00

... (test volumes, sales forecasts, supplier shares) $5,500. This new 327-page report from Venture Planning Group contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and ...

November 2013 327 pages

2014 Analysis of the French Endocrine Function Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the French endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and ...

November 2013 269 pages

2014 Analysis of the German Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices

US$ 1,960.00

This new 271-page report from Venture Planning Group provides a comprehensive analysis in the German endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and ...

November 2013 271 pages

2014 Analysis of the Italian Endocrine Function Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Italian endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and ...

November 2013 269 pages

2014 Analysis of the Japanese Endocrine Function Testing Market: Hospitals and Commercial Labs

US$ 2,200.00

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume ...

November 2013 269 pages

2014 Analysis of the Spanish Endocrine Function Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 1,960.00

This new 271-page report from Venture Planning Group provides a comprehensive analysis in the Spanish endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and ...

November 2013 271 pages

2014 Analysis of the UK Endocrine Function Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 269-page report from Venture Planning Group provides a comprehensive analysis in the UK endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and ...

November 2013 269 pages

2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices

US$ 2,800.00

This new 271-page report from Venture Planning Group provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and ...

November 2013 271 pages

2014 Analysis of the European Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers

US$ 5,200.00

This new 310-page report from Venture Planning Group provides a comprehensive analysis of the European endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume ...

November 2013 310 pages

2014 Analysis of the Global Immunoprotein Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan

US$ 6,800.00

... volumes, sales forecasts, supplier shares) $5,500. This new 297-page report from Venture Planning Group contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...

November 2013 297 pages

2014 Analysis of the US Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Physician Offices

US$ 2,800.00

This new 236-page report from Venture Planning Group provides analysis of the US immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 236 pages

2014 Analysis of the French Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the French immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 234 pages

2014 Analysis of the German Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Physician Offices

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the German immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 236 pages

2014 Analysis of the Italian Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 233-page report from Venture Planning Group provides analysis of the Italian immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 233 pages

2014 Analysis of the Japanese Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 2,200.00

This new 234-page report from Venture Planning Group provides analysis of the Japanese immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 234 pages

2014 Analysis of the Spanish Immunoprotein Diagnostic Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 1,960.00

This new 236-page report from Venture Planning Group provides analysis of the Spanish immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 236 pages

2014 Analysis of the UK Immunoprotein Diagnostic Testing Market: Hospitals and Commercial Labs

US$ 1,960.00

This new 234-page report from Venture Planning Group provides analysis of the UK immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 234 pages

2014 Analysis of the European Immunoprotein Diagnostic Testing Market: Hospital, Commercial Labs, Physician Offices, Ambulatory Care Centers

US$ 5,200.00

This new 273-page report from Venture Planning Group provides analysis of the European immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by ...

November 2013 273 pages

2014 Analysis of the US Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

US$ 4,320.00

... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, ...

November 2013 314 pages

2014 Analysis of the European Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

US$ 7,520.00

... 363-page report from Venture Planning Group provides analysis of the European enteric disease testing market, including emerging tests, technologies, ... . About this Report This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK). Current scientific ...

November 2013 363 pages

2014 Analysis of the US Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

US$ 3,600.00

... This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests ... , and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Current scientific views on epidemiology and ...

November 2013 278 pages

2014 Analysis of the European Sexually-Transmitted Disease Testing Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

US$ 6,320.00

... 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, ... profiles of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views ...

November 2013 318 pages

Analysis of the Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan

US$ 6,800.00

... Venture Planning Group contains 83 tables and provides analysis of the global tumor markers and special chemistry testing market, including emerging ... , such as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany ...

November 2013 320 pages

2014 Analysis of the German Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

November 2013 61 pages

2014 Analysis of the Italian Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry ...

November 2013 57 pages

2014 Analysis of the Japanese Diagnostic Testing Market: Segment Forecasts and Supplier Shares

US$ 3,880.00

This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry ...

November 2013 60 pages

Filters

Search

Categories

675
84
1,065
33,609
152
69
819
657
1,866
4,252
70

Publishers

1
8
9
36
1
15
4
40
1
1
17
12
4
1
1
13
2
1
53
1
1
9
9
328
1
2
1
5
16
1
1
13
4
40
1
2
8
5
16
19
36
7
10
6
2
3
174
108
13
53
3
29
15
1
4
7
18
3
24
3
32
1
15
2
7
2
81
45
11
78
1
14
2
22
3
74
41,216
1
40
2
17
15
24
85
6
10
51
11
62
48
1
45
23
49

Regions

280
15
1
134
138
137
137
136
136
135
134
131
130
175
38
16,410
447
192
191
191
137
4
3
2
198
197
196
196
196
195
194
194
194
192
106
193
195
193
192
107
195
138
203
194
189
200
198
196
139
105
195
194
194
193
195
176
198
197
138
112
197
197
195
195
193
193
138
138
136
135
135
1
1
200
198
197
195
194
198
197
196
195
195
195
194
194
194
195
195
191
138
138
137
108
16
1
1
198
1
108
1,215
1,213
1,197
1,192
1,172
245
2
263
194
195
203
197
1,227
1,153
1,668

Price

Date

Pages

Offers

34
6
1
15
84